Targeting the USP7-CDK1 axis suppresses estrogen receptor-positive breast cancer progression.
- Published in:
- Cancer Cell International, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12935-025-03693-2
- By:
- Publication type:
- Article
Works by Chen, Yun-Cen
Results: 2
1
2
USP7 Induces Chemoresistance in Triple-Negative Breast Cancer via Deubiquitination and Stabilization of ABCB1.
- Published in:
- Cells (2073-4409), 2022, v. 11, n. 20, p. 3294, doi. 10.3390/cells11203294
- By:
- Publication type:
- Article